Schonfeld Strategic Advisors LLC Spring Works Therapeutics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 140,106 shares of SWTX stock, worth $4.18 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
140,106
Previous 242,173
42.15%
Holding current value
$4.18 Million
Previous $11.9 Million
55.73%
% of portfolio
0.04%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding SWTX
# of Institutions
223Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$195 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$167 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$110 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$107 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$102 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $1.86B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...